Abstract
Insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) are essential regulators for osteoblast proliferation and differentiation. It has been reported that Dexamethasone (Dex), an active glucocorticoid (GC) analogue, synergizes the stimulatory effect of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) on osteoblast differentiation in the mouse fibroblastic cell line NIH3T3. I investigated whether this stimulatory effect is associated with changes in the expression pattern of the IGF/IGFBP system. Quantitative real-time PCR technology was used to quantify the gene expression levels of the IGF-system during osteoblast differentiation and in response to 1,25(OH)2D3 or Dex alone under serum-containing and serum-free culture conditions. Interestingly, NIH3T3 was shown to express high mRNA levels of IGF-I, IGF-II and IGFBP-5, and low levels of both IGFBP-2 and-6. During osteoblast differentiation (days 6-12), IGF-I mRNA was repressed by more than 60%, while the transcript of IGFBP-5 was markedly up-regulated, by more than 50-fold. Similarly, treatment with Dex alone resulted in a dose-and time-dependent increase in the expression of IGFBP-5 and a decrease in IGF-I mRNA. Treatment with 1,25(OH)2D3 alone increased the mRNA levels of IGF-I and IGFBP-6 by around 4-and 7-fold, respectively, in a dose-and time-dependent manner. In conclusion, my data demonstrated that osteoblast differentiation of NIH3T3 is associated with changes in the expression pattern of IGFs/IGFBPs, which are regulated by glucocorticoid in the presence of 1,25(OH)2D3. Modulation of the IGF/IGFBP levels by glucocorticoid might suggest important roles for the IGF-system in mediating the osteoblast differentiation of the NIH3T3 cell line.
[1] Kassem, M., Kristiansen, M. and Abdallah, B.M. Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin. Pharmacol. Toxicol. 95 (2004) 209–214. http://dx.doi.org/10.1111/j.1742-7843.2004.pto950502.x10.1111/j.1742-7843.2004.pto950502.xSearch in Google Scholar
[2] Langdahl, B.L., Kassem, M., Moller, M.K. and Eriksen, E.F. The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone. Eur. J. Clin. Invest. 28 (1998) 176–183. http://dx.doi.org/10.1046/j.1365-2362.1998.00265.x10.1046/j.1365-2362.1998.00265.xSearch in Google Scholar
[3] Rajaram, S., Baylink, D.J. and Mohan, S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr. Rev. 18 (1997) 801–831. http://dx.doi.org/10.1210/er.18.6.80110.1210/er.18.6.801Search in Google Scholar
[4] Mohan, S. and Baylink, D.J. IGF-binding proteins are multifunctional and act via IGF-dependent and-independent mechanisms. J. Endocrinol. 175 (2002) 19–31. http://dx.doi.org/10.1677/joe.0.175001910.1677/joe.0.1750019Search in Google Scholar
[5] Robson, H., Siebler, T., Shalet, S.M. and Williams, G.R. Interactions between GH, IGF-I, glucocorticoids, and thyroid hormones during skeletal growth. Pediatr. Res. 52 (2002) 137–147. http://dx.doi.org/10.1203/01.PDR.0000023494.70201.1C10.1203/01.PDR.0000023494.70201.1CSearch in Google Scholar
[6] Eijken, M., Koedam, M., van Driel, M., Buurman, C.J., Pols, H.A. and van Leeuwen, J.P. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol. Cell Endocrinol. 248 (2006) 87–93. http://dx.doi.org/10.1016/j.mce.2005.11.03410.1016/j.mce.2005.11.034Search in Google Scholar
[7] Delany, A.M. and Canalis, E. Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cells. Endocrinology 136 (1995) 4776–4781. http://dx.doi.org/10.1210/en.136.11.477610.1210/endo.136.11.7588206Search in Google Scholar
[8] Cheng, S.L., Zhang, S.F., Mohan, S., Lecanda, F., Fausto, A., Hunt, A.H., Canalis, E. and Avioli, L.V. Regulation of insulin-like growth factors I and II and their binding proteins in human bone marrow stromal cells by dexamethasone. J. Cell Biochem. 71 (1998) 449–458. http://dx.doi.org/10.1002/(SICI)1097-4644(19981201)71:3<449::AID-JCB13>3.0.CO;2-D10.1002/(SICI)1097-4644(19981201)71:3<449::AID-JCB13>3.0.CO;2-DSearch in Google Scholar
[9] Gurlek, A., Pittelkow, M.R. and Kumar, R. Modulation of growth factor/cytokine synthesis and signaling by 1alpha,25-dihydroxyvitamin D(3): implications in cell growth and differentiation. Endocr. Rev. 23 (2002) 763–786. http://dx.doi.org/10.1210/er.2001-004410.1210/er.2001-0044Search in Google Scholar
[10] Kveiborg, M., Flyvbjerg, A., Eriksen, E.F. and Kassem, M. 1,25-Dihydroxyvitamin D3 stimulates the production of insulin-like growth factor-binding proteins-2,-3 and-4 in human bone marrow stromal cells. Eur. J. Endocrinol. 144 (2001) 549–557. http://dx.doi.org/10.1530/eje.0.144054910.1530/eje.0.1440549Search in Google Scholar
[11] Nakao, Y., Hilliker, S., Baylink, D.J. and Mohan, S. Studies on the regulation of insulin-like growth factor binding protein 3 secretion in human osteosarcoma cells in vitro. J. Bone Miner. Res. 9 (1994) 865–872. http://dx.doi.org/10.1002/jbmr.565009061210.1002/jbmr.5650090612Search in Google Scholar
[12] Shui, C. and Scutt, A.M. Mouse embryo-derived NIH3T3 fibroblasts adopt an osteoblast-like phenotype when treated with 1alpha,25-dihydroxyvitamin D(3) and dexamethasone in vitro. J. Cell Physiol. 193 (2002) 164–172. http://dx.doi.org/10.1002/jcp.1015710.1002/jcp.10157Search in Google Scholar
[13] Wang, E.A., Israel, D.I., Kelly, S. and Luxenberg, D.P. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9 (1993) 57–71. Search in Google Scholar
[14] Xiao, Z.S., Hinson, T.K. and Quarles, L.D. Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells. J. Cell Biochem. 74 (1999) 596–605. http://dx.doi.org/10.1002/(SICI)1097-4644(19990915)74:4<596::AID-JCB9>3.0.CO;2-F10.1002/(SICI)1097-4644(19990915)74:4<596::AID-JCB9>3.0.CO;2-FSearch in Google Scholar
[15] Abdallah, B.M., Haack-Sorensen, M., Fink, T. and Kassem, M. Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone 39 (2006) 181–188. http://dx.doi.org/10.1016/j.bone.2005.12.08210.1016/j.bone.2005.12.082Search in Google Scholar
[16] Koch, H., Jadlowiec, J.A. and Campbell, P.G. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev. 14 (2005) 621–631. http://dx.doi.org/10.1089/scd.2005.14.62110.1089/scd.2005.14.621Search in Google Scholar
[17] Barnes, P.J. Corticosteroids: the drugs to beat. Eur. J. Pharmacol. 533 (2006) 2–14. http://dx.doi.org/10.1016/j.ejphar.2005.12.05210.1016/j.ejphar.2005.12.052Search in Google Scholar
[18] Canalis, E., Bilezikian, J.P., Angeli, A. and Giustina, A. Perspectives on glucocorticoid-induced osteoporosis. Bone 34 (2004) 593–598. http://dx.doi.org/10.1016/j.bone.2003.11.02610.1016/j.bone.2003.11.026Search in Google Scholar
[19] Smith, E., Coetzee, G.A. and Frenkel, B. Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3beta. J. Biol. Chem. 277 (2002) 18191–18197. http://dx.doi.org/10.1074/jbc.M10970820010.1074/jbc.M109708200Search in Google Scholar
[20] Jorgensen, N.R., Henriksen, Z., Sorensen, O.H. and Civitelli, R. Dexamethasone, BMP-2and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69 (2004) 219–226. http://dx.doi.org/10.1016/j.steroids.2003.12.00510.1016/j.steroids.2003.12.005Search in Google Scholar
[21] Minuto, F., Palermo, C., Arvigo, M. and Barreca, A.M. The IGF system and bone. J. Endocrinol. Invest. 28 (2005) 8–10. Search in Google Scholar
[22] Chen, T.L., Mallory, J.B. and Hintz, R.L. Dexamethasone and 1,25(OH)2 vitamin D3 modulate the synthesis of insulin-like growth factor-I insteoblast-like cells. Calcif. Tissue Int. 48 (1991) 278–282. Search in Google Scholar
[23] Chevalley, T., Strong, D.D., Mohan, S., Baylink, D. and Linkhart, T.A. Evidence for a role for insulin-like growth factor binding proteins in glucocorticoid inhibition of normal human osteoblast-like cell proliferation. Eur. J. Endocrinol. 134 (1996) 591–601. http://dx.doi.org/10.1530/eje.0.134059110.1530/eje.0.1340591Search in Google Scholar
[24] Conover, C.A., Clarkson, J.T. and Bale, L.K. Effect of glucocorticoid on insulin-like growth factor (IGF) regulation of IGF-binding protein expression in fibroblasts. Endocrinology 136 (1995) 1403–1410. http://dx.doi.org/10.1210/en.136.4.140310.1210/endo.136.4.7534698Search in Google Scholar
[25] Fielder, P.J., Tauber, J.P., Wilson, K.F., Pham, H.M. and Rosenfeld, R.G. Insulin-like growth factors (IGFs) stimulate and dexamethasone inhibits IGF binding protein (BP)-5 expression in a mouse pituitary cell line. Growth Regul. 3 (1993) 226–234. Search in Google Scholar
[26] Firth, S.M. and Baxter, R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23 (2002) 824–854. http://dx.doi.org/10.1210/er.2001-003310.1210/er.2001-0033Search in Google Scholar
[27] Miyakoshi, N., Richman, C., Kasukawa, Y., Linkhart, T.A., Baylink, D.J. and Mohan, S. Evidence that IGF-binding protein-5 functions as a growth factor. J. Clin. Invest. 107 (2001) 73–81. http://dx.doi.org/10.1172/JCI1045910.1172/JCI10459Search in Google Scholar
[28] Durant, D., Pereira, R.M. and Canalis, E. Overexpression of insulin-like growth factor binding protein-5 decreases osteoblastic function in vitro. Bone 35 (2004) 1256–1262. http://dx.doi.org/10.1016/j.bone.2004.08.01110.1016/j.bone.2004.08.011Search in Google Scholar
[29] Jia, D. and Heersche, J.N. Expression of insulin-like growth factor system constituents in differentiating rat osteoblastic cell populations. Growth Horm. IGF. Res. 12 (2002) 399–410. http://dx.doi.org/10.1016/S1096-6374(02)00117-X10.1016/S1096-6374(02)00117-XSearch in Google Scholar
[30] Chen, T.L., Chang, L.Y., Bates, R.L. and Perlman, A.J. Dexamethasone and 1,25-dihydroxyvitamin D3 modulation of insulin-like growth factor-binding proteins in rat osteoblast-like cell cultures. Endocrinology 128 (1991) 73–80. Search in Google Scholar
[31] Chenu, C., Valentin-Opran, A., Chavassieux, P., Saez, S., Meunier, P.J. and Delmas, P.D. Insulin like growth factor I hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term cultures. Bone 11 (1990) 81–86. http://dx.doi.org/10.1016/8756-3282(90)90054-310.1016/8756-3282(90)90054-3Search in Google Scholar
[32] Linkhart, T.A. and Keffer, M.J. Differential regulation of insulin-like growth factor-I (IGF-I) and IGF-II release from cultured neonatal mouse calvaria by parathyroid hormone, transforming growth factor-betaand 1,25-dihydroxyvitamin D3. Endocrinology 128 (1991) 1511–1518. http://dx.doi.org/10.1210/endo-128-3-151110.1210/endo-128-3-1511Search in Google Scholar
[33] Schmid, C., Schlapfer, I., Gosteli-Peter, M.A., Hauri, C., Froesch, E.R. and Zapf, J. 1 alpha,25-dihydroxyvitamin D3 increases IGF binding protein-5 expression in cultured osteoblasts. FEBS Lett. 392 (1996) 21–24. http://dx.doi.org/10.1016/0014-5793(96)00777-610.1016/0014-5793(96)00777-6Search in Google Scholar
[34] Kim, E.J., Schaffer, B.S., Kang, Y.H., Macdonald, R.G. and Park, J.H. Decreased production of insulin-like growth factor-binding protein (IGFBP)-6 by transfection of colon cancer cells with an antisense IGFBP-6 cDNA construct leads to stimulation of cell proliferation. J. Gastroenterol. Hepatol. 17 (2002) 563–570. http://dx.doi.org/10.1046/j.1440-1746.2002.02703.x10.1046/j.1440-1746.2002.02703.xSearch in Google Scholar PubMed
[35] Schmid, C. Insulin-like growth factors. Cell Biol. Int. 19 (1995) 445–457. http://dx.doi.org/10.1006/cbir.1995.108810.1006/cbir.1995.1088Search in Google Scholar PubMed
[36] Yan, T., Wergedal, J., Zhou, Y., Mohan, S., Baylink, D.J. and Strong, D.D. Inhibition of human osteoblast marker gene expression by retinoids is mediated in part by insulin-like growth factor binding protein-6. Growth Horm. IGF. Res. 11 (2001) 368–377. http://dx.doi.org/10.1054/ghir.2001.024910.1054/ghir.2001.0249Search in Google Scholar PubMed
[37] Bach, L.A. IGFBP-6 five years on; not so ‘forgotten’? Growth Horm. IGF. Res. 15 (2005) 185–192. http://dx.doi.org/10.1016/j.ghir.2005.04.00110.1016/j.ghir.2005.04.001Search in Google Scholar PubMed
© 2006 University of Wrocław, Poland
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
